<p>Regimens for the treatment of tuberculosis in a hypothetical cohort of TB patients in the setting of anti-TB drug shortages<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134597#t001fn001" target="_blank"><sup>a</sup></a><sup>,</sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134597#t001fn002" target="_blank"><sup>b</sup></a>.</p
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis usually attack the lung...
Drug-resistant tuberculosis (DR-TB) has been an area of growing concern and posing threat to human h...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
BackgroundThe WHO has issued a call to action urging countries to accelerate the rollout of new WHO-...
BackgroundFrom 2012 through 2014, the United States experienced acute shortages and price escalation...
From 2012 through 2014, the United States experienced acute shortages and price escalations of sever...
Statement of the Problem: Approximately ten million people develop tuberculosis (TB) each year, and ...
For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommen...
Development of new, effective, and affordable tuberculosis (TB) therapies has been identified as a c...
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB...
Abstract Tuberculosis (TB) is considered as one of the most serious threats to public health in many...
Antimicrobial resistance is a serious problem because of the scarcity of new antibiotics effective a...
BACKGROUND: Recent years have seen important improvements in available preventive treatment regimens...
The last 120 years have witnessed the discovery of very effective drugs for the treatment of tubercu...
agents, hope dawned on the gloomy world of patients of tuberculosis. By the end of the 20th century,...
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis usually attack the lung...
Drug-resistant tuberculosis (DR-TB) has been an area of growing concern and posing threat to human h...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...
BackgroundThe WHO has issued a call to action urging countries to accelerate the rollout of new WHO-...
BackgroundFrom 2012 through 2014, the United States experienced acute shortages and price escalation...
From 2012 through 2014, the United States experienced acute shortages and price escalations of sever...
Statement of the Problem: Approximately ten million people develop tuberculosis (TB) each year, and ...
For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommen...
Development of new, effective, and affordable tuberculosis (TB) therapies has been identified as a c...
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB...
Abstract Tuberculosis (TB) is considered as one of the most serious threats to public health in many...
Antimicrobial resistance is a serious problem because of the scarcity of new antibiotics effective a...
BACKGROUND: Recent years have seen important improvements in available preventive treatment regimens...
The last 120 years have witnessed the discovery of very effective drugs for the treatment of tubercu...
agents, hope dawned on the gloomy world of patients of tuberculosis. By the end of the 20th century,...
Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis usually attack the lung...
Drug-resistant tuberculosis (DR-TB) has been an area of growing concern and posing threat to human h...
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1.5 million people die...